Form 4: Petco Director Cameron Breitner Receives Equity Grant
Insider Transaction Report
Petco Health & Wellness Company Director Cameron Breitner was granted 43,422 restricted stock units, increasing his direct beneficial ownership.
Summary
- Director Cameron Breitner of Petco Health & Wellness Company, Inc. was granted 43,422 restricted stock units (RSUs) of Class A common stock on July 24, 2025.
- Each RSU represents the right to receive one share of the Issuer's Class A common stock.
- The RSUs were granted at a price of $0, indicating they are part of an equity compensation plan.
- The RSUs are set to vest on the earlier of the Issuer's next annual shareholder meeting or July 24, 2026.
- Following this transaction, Director Breitner's direct beneficial ownership of Class A common stock is 92,676 shares.
- Additionally, Director Breitner holds an indirect beneficial ownership of 750,000 shares of Class A common stock through a trust.
Sentiment
Score: 7
Explanation: The filing reports a routine equity grant to a director, which is a positive for aligning interests but does not indicate significant new operational or financial developments. It's a standard, expected event.
Positives
- The grant of restricted stock units to a director aligns management's interests with those of shareholders, incentivizing long-term performance.
- The equity grant is a standard component of executive and director compensation, reflecting ongoing commitment to the company.
Future Outlook
The granted restricted stock units are scheduled to vest on the earlier of the company's next annual shareholder meeting or July 24, 2026, indicating a future increase in the director's direct shareholding upon vesting.
Industry Context
The grant of restricted stock units to a director is a common practice across publicly traded companies, serving as a key component of executive and director compensation packages designed to align leadership incentives with shareholder value creation.
Comparison to Industry Standards
- The grant of restricted stock units to a director is a standard compensation practice widely adopted by companies across various industries, including retail and pet care, to attract and retain qualified board members.
- Similar equity compensation structures are observed in comparable companies within the pet industry, such as Chewy, Inc. (CHWY) and Freshpet, Inc. (FRPT), where director compensation often includes a mix of cash and equity awards to foster long-term commitment and performance alignment.
Related Party Transactions
- Grant of 43,422 restricted stock units to Director Cameron Breitner under the Petco Health and Wellness Company, Inc. 2021 Equity Incentive Plan, as amended.
Stakeholder Impact
- Shareholders: The equity grant aligns the director's financial interests with shareholder value, potentially leading to more shareholder-centric decision-making.
- Employees: No direct impact on general employees is indicated by this specific filing.
Next Steps
- The restricted stock units will vest on the earlier of the Issuer's next annual shareholder meeting or July 24, 2026, at which point they will convert into Class A common stock shares.
Key Dates
| Date | Description |
|---|---|
| 07/24/2025 | Date of RSU grant to Director Cameron Breitner. |
| 07/28/2025 | Date the Form 4 filing was signed and submitted. |
| 07/24/2026 | Latest possible vesting date for the granted restricted stock units. |
| Next Annual Shareholder Meeting | Earlier vesting condition for the restricted stock units. |
Recommendation
holdThis Form 4 reports a routine equity grant to an existing director, which is a standard compensation practice and does not provide new material information that would warrant a change in investment recommendation. The transaction itself is not indicative of a significant shift in the company's fundamentals or outlook.
Keywords
Petco, WOOF, Director, Equity Grant, Restricted Stock Units, RSU, Insider Transaction, Beneficial Ownership, Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.